Skip to main content
Clinical Trials/EUCTR2012-003219-77-DK
EUCTR2012-003219-77-DK
Active, not recruiting
Phase 1

Effects on Exercise Hemodynamics of Vasopressin Blockade by Conivaptan Infusion in Heart Failure

Copenhagen University Hospital, Rigshospitalet0 sites20 target enrollmentDecember 20, 2012

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Heart Failure
Sponsor
Copenhagen University Hospital, Rigshospitalet
Enrollment
20
Status
Active, not recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 20, 2012
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Copenhagen University Hospital, Rigshospitalet

Eligibility Criteria

Inclusion Criteria

  • \-Age \> 18 years
  • \-LVEF \< 45 %
  • \-Treatment with beta\-blockers and ACE\-inhibitors for at least 1 month
  • \-NYHA\-class II\-III
  • \-Given informed consent
  • Women, who have not yet entered menopause (defined as no menstrual bleeding in the last 12 months), will provide a negative urine HCG before entering the study
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 15

Exclusion Criteria

  • \-Signs of symptomatic or ongoing myocardial ischemia
  • \-Presence of hypovolemic hyponatremia (as judged by the investigator)
  • \-Clinical signs of volume depletion or dehydration
  • \-Hypernatremia (P\-Na\+) \> 145 mmol/L
  • \-Chronic obstructive pulmonary disease (FEV1 \< 1L)
  • \-Supine systolic blood pressure \< 85 mmHg
  • \-Significant orthostatic hypotension
  • \-standing blood pressure \< 80 mmHg or a blood pressure drop \> 20 mmHg when changing from a supine to a standing position
  • \-Uncontrolled hypertension
  • \-Uncontrolled cardiac arrhythmias

Outcomes

Primary Outcomes

Not specified

Similar Trials